- News & Events
- Contact Us
Amgen Announces Award for Science Teaching Excellence in King and Snohomish CountiesFOR IMMEDIATE RELEASE
Seattle, Washington, January 24, 2003 - Amgen (NASDAQ:AMGN) announced today it is launching the Amgen Award for Science Teaching Excellence in King and Snohomish counties, its recognition program for science education. Two K-12 educators who work in either public or private schools in those two counties will each receive an unrestricted $10,000 award from Amgen, and will be honored at an award dinner in May.
For 11 years, Amgen has conducted the Amgen Award for Teacher Excellence. Last year, Amgen modified the award to focus solely on excellence in science teaching. This is the first year the Amgen Award for Science Teaching Excellence has been directed toward teachers in King and Snohomish counties; Amgen acquired Seattle-based Immunex in July 2002. Amgen also conducts similar programs in California; Colorado; Louisville, Kentucky; Puerto Rico, and Rhode Island.
Anyone can nominate an educator who teaches science. The nomination letter should include: the full name of the teacher; the name and address of the school; the name of the school district; the school's phone number; the grade level the science teacher teaches; the nominator's relationship to the science teacher; the nominator's phone number; and a description of why the science teacher deserves the award. The letter should describe the teacher's attributes in the areas of creativity, teaching effectiveness, best practice development, and instructional and motivational ability.
Letters should be sent to: Amgen's Award for Science Teaching Excellence, Amgen Inc., Janis Wignall, 51 University Street, Seattle, WA 98101. Nominations can also be submitted electronically, at http://www.Amgen.com/corporate/AmgenTeacher/index.html. Nominations for the award will be accepted immediately, through February 28, 2003.
Amgen is a global biotechnology company that discovers, develops, manufactures and markets important human therapeutics based on advances in cellular and molecular biology.
Barbara Bronson Gray: 805/447-4949
Amgen, Corporate Communications
EDITOR'S NOTES: An electronic version of this news release may be accessed via our web site at http://www.amgen.com.